Segall Bryant & Hamill’s LeMaitre Vascular LMAT Stock Holding History

Segall Bryant & Hamill’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.05M	Buy	52,596 +344	+0.7%	+$35.3K	0.06%	320
2026 Q1	$5.7M	Sell	52,252 -27,990	-35%	-$2.67M	0.08%	291
2025 Q4	$6.51M	Sell	80,242 -4,917	-6%	-$423K	0.09%	286
2025 Q3	$7.45M	Buy	85,159 +2,364	+3%	+$211K	0.1%	271
2025 Q2	$6.88M	Buy	82,795 +6,335	+8%	+$529K	0.1%	280
2025 Q1	$6.41M	Buy	76,460 +17,354	+29%	+$1.61M	0.1%	279
2024 Q4	$5.45M	Buy	+59,106	New	+$5.68M	0.07%	317
2020 Q3	–	Sell	-35,657	Closed	-$941K	–	749
2020 Q2	$941K	Sell	35,657 -36,650	-51%	-$958K	0.02%	453
2020 Q1	$1.8M	Buy	72,307 +37,352	+107%	+$1.15M	0.04%	348
2019 Q4	$1.26M	Sell	34,955 -27,198	-44%	-$939K	0.02%	479
2019 Q3	$2.12M	Buy	+62,153	New	+$1.99M	0.03%	400

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Segall Bryant & Hamill's LMAT Position: Q2 2026 in Review

Segall Bryant & Hamill increased its LeMaitre Vascular (LMAT) stake by 0.66% in Q2 2026, buying an estimated $35.3K and bringing the position to 52,596 shares worth $5.05M. The position accounts for 0.06% of the portfolio, ranked #320.

Segall Bryant & Hamill first reported a position in LMAT in Q3 2019 and has held it in 11 quarters since. The position peaked at $7.45M in Q3 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Segall Bryant & Hamill held 52,596 shares of LeMaitre Vascular worth $5.05M as of Q2 2026.
Segall Bryant & Hamill bought 344 LeMaitre Vascular shares in Q2 2026, an estimated $35.3K.
LeMaitre Vascular made up 0.06% of Segall Bryant & Hamill's portfolio in Q2 2026, its #320 holding.
Segall Bryant & Hamill first reported a position in LeMaitre Vascular in Q3 2019 and has held it in 11 quarters since.
Segall Bryant & Hamill's LeMaitre Vascular position peaked at $7.45M in Q3 2025.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.